Oxidative stress and mitochondrial dysfunction in Down syndrome.

Area of Science:

• Genetics
• Neuroscience
• Immunology

Background:

• Down syndrome (DS), or trisomy 21, is a prevalent genetic disorder with neurological and clinical manifestations.
• DS-associated neurodegeneration shares similarities with Alzheimer disease (AD), including dementia and amyloid plaques.
• DS is linked to redox imbalance, particularly due to Cu,Zn-superoxide dismutase (SOD-1) overexpression from chromosome 21.

Purpose of the Study:

• To review the role of oxidative stress and mitochondrial dysfunction in Down syndrome.
• To explore the connection between immune defects, inflammation, and the prooxidant state in DS.
• To summarize findings on mitochondrial abnormalities in human DS patients and trisomy 16 (Ts16) mice.

Main Methods:

• Review of existing literature on Down syndrome, oxidative stress, and mitochondrial function.
• Analysis of ultrastructural and biochemical data from human DS patients and Ts16 mouse models.
• Integration of findings related to genetic, immunologic, and metabolic alterations in DS.

Main Results:

• Overexpression of SOD-1 contributes to redox imbalance and oxidative stress in DS.
• Immunologic defects in DS lead to a proinflammatory state, exacerbating oxidative stress.
• Mitochondrial ultrastructural and biochemical abnormalities are consistently observed in DS, indicating dysfunction.

Conclusions:

• Mitochondrial dysfunction is a significant factor in the prooxidant state observed in Down syndrome.
• Oxidative stress and inflammation are key phenotypic hallmarks of Down syndrome.
• Understanding these mechanisms is crucial for developing therapeutic strategies for DS.